The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Ferumoxytol for Treating Iron Deficiency Anemia in CKD
Open accessAbstract
Iron deficiency is an important cause of anemia in patients with chronic kidney disease (CKD), but intravenous iron is infrequently used among patients who are not on dialysis. Ferumoxytol is a novel intravenous iron product that can be administered as a rapid injection. This Phase III trial randomly assigned 304 patients with CKD in a 3:1 ratio to two 510-mg doses of intravenous ferumoxytol within 5 +/- 3 d or 200 mg of elemental oral iron daily for 21 d. The increase in hemoglobin at day 35, the primary efficacy end point, was 0.82 +/- 1.24 g/dl with ferumoxytol and 0.16 +/- 1.02 g/dl with oral iron (P < 0.0001). Among patients who were not receiving erythropoiesis-stimulating agents, hemoglobin increased 0.62 +/- 1.02 g/dl with ferumoxytol and 0.13 +/- 0.93 g/dl with oral iron. Among patients who were receiving erythropoiesis-stimulating agents, hemoglobin increased 1.16 +/- 1.49 g/dl with ferumoxytol and 0.19 +/- 1.14 g/dl with oral iron. Treatment-related adverse events occurred in 10.6% of patients who were treated with ferumoxytol and 24.0% of those who were treated with oral iron; none was serious. In summary, a regimen of two doses of 510 mg of intravenous ferumoxytol administered rapidly within 5 +/- 3 d was well tolerated and had the intended therapeutic effect. This regimen may offer a new, efficient option to treat iron deficiency anemia in patients with CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K.-U., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,104
Hofstra, L., Tordoir, J. H. M., Kitslaar, P. J. E. H. M., Hoeks, A. P. G., & Daemen, M. J. A. P. (1996) · Circulation · doi:10.1161/01.cir.94.6.1283 · Cited by 1,603
Clinical Practice Guidelines for Vascular Access
(2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.04.040 · Cited by 1,593
Kalantar-Zadeh, K. (2017) · American Journal of Nephrology · doi:10.1159/000455387 · Cited by 1,148
(2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.03.010 · Cited by 829
Locatelli, F. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1032 · Cited by 785
Astor, B. C., Muntner, P., Levin, A., Eustace, J. A., & Coresh, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.12.1401 · Cited by 716
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
Update on adverse drug events associated with parenteral iron
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmén, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi253 · Cited by 457
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
Eschbach, J. W. (1989) · Kidney International · doi:10.1038/ki.1989.18 · Cited by 408
(2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.03.011 · Cited by 311
Intravenous Iron Dextran in Clinical Medicine
Hamstra, R. D. (1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03300430028018 · Cited by 280
Optimization of Epoetin Therapy with Intravenous Iron Therapy in Hemodialysis Patients
BESARAB, A., AMIN, N., AHSAN, M., VOGEL, S. E., ZAZUWA, G., FRINAK, S., ZAZRA, J. J., ANANDAN, J. V., & GUPTA, A. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113530 · Cited by 273
OBRADOR, G. T., RUTHAZER, R., ARORA, P., KAUSZ, A. T., & PEREIRA, B. J. G. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1081793 · Cited by 244
Self-citationVan Wyck, D. B., Roppolo, M., Martinez, C. O., Mazey, R. M., & Mcmurray, S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00758.x · Cited by 226
Radtke, H., Claussner, A., Erbes, P., Scheuermann, E., Schoeppe, W., & Koch, K. (1979) · Blood · doi:10.1182/blood.v54.4.877.877 · Cited by 224
Anemia: An early complication of chronic renal insufficiency
Kazmi, W. H., Kausz, A. T., Khan, S., Abichandani, R., Ruthazer, R., Obrador, G. T., & Pereira, B. J. G. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27699 · Cited by 222
Self-citationMichael, B., Coyne, D. W., Fishbane, S., Folkert, V., Lynn, R., Nissenson, A. R., Agarwal, R., Eschbach, J. W., Fadem, S. Z., Trout, J. R., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00314.x · Cited by 199
Strategies for iron supplementation: Oral versus intravenous
Macdougall, I. C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055suppl.69061.x · Cited by 199
Intravenous iron sucrose: Establishing a safe dose
Chandler, G., Harchowal, J., & Macdougall, I. C. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.28587 · Cited by 198
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era
Kalantar-Zadeh, K., Höffken, B., Wünsch, H., Fink, H., Kleiner, M., & Luft, F. C. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90649-5 · Cited by 183
Iron management in end-stage renal disease
Fishbane, S., & Maesaka, J. K. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90192-x · Cited by 174
Iron Status and Hemoglobin Level in Chronic Renal Insufficiency
Hsu, C.-Y., McCulloch, C. E., & Curhan, G. C. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034200.82278.dc · Cited by 172
Hypersensitivity reactions and deaths associated with intravenous iron preparations
Bailie, G. R., Clark, J. A., Lane, C. E., & Lane, P. L. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh820 · Cited by 164
Fishbane, S. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00373-1 · Cited by 142
Gotloib, L., Silverberg, D. S., Fudin, R., & Shostak, A. (2006) · Journal of Nephrology · doi:10.1093/joneph/19.2.161 · Cited by 136
Suspected iron dextran-related adverse drug events in hemodialysis patients
Fletes, R., Lazarus, J. M., Gage, J. O., & Chertow, G. M. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80123-2 · Cited by 135
Cardiac function and hematocrit level
Harnett, J. D., Kent, G. M., Foley, R. N., & Parfrey, P. S. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90673-8 · Cited by 134
Management of Patients with Chronic Renal Insufficiency in the Northeastern United States
Kausz, A. T., Khan, S. S., Abichandani, R., Kazmi, W., Obrador, G. T., Ruthazer, R., & Pereira, B. J. G. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271501 · Cited by 132
Self-citationCharytan, C., Qunibi, W. Y., & Bailie, G. R. (2005) · Nephron Clinical Practice · doi:10.1159/000085049 · Cited by 129
A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease
Agarwal, R., Rizkala, A. R., Bastani, B., Kaskas, M. O., Leehey, D. J., & Besarab, A. (2006) · American Journal of Nephrology · doi:10.1159/000096174 · Cited by 127
Landry, R., Jacobs, P. M., Davis, R., Shenouda, M., & Bolton, W. K. (2005) · American Journal of Nephrology · doi:10.1159/000087212 · Cited by 108
Kooistra, M. P., Niemantsverdriet, E. C., van Es, A., Mol-Beermann, N. M., Struyvenberg, A., & Marx, J. J. M. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.1.82 · Cited by 102
Sepandj, F., Jindal, K., West, M. L., & Hirsch, D. J. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027260 · Cited by 82
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients
Spinowitz, B., Schwenk, M. H., Jacobs, P. M., Bolton, W. K., Kaplan, M. R., Charytan, C., & Galler, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00598.x · Cited by 74
Self-citationMacdougall, I. C., & Roche, A. J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.032 · Cited by 68
Intravenous iron for the treatment of predialysis anemia
Silverberg, D. S., Blum, M., Agbaria, Z., Schwartz, D., Zubkov, A., Yachnin, T., & Iaina, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055suppl.69079.x · Cited by 54
Prakash, S., Walele, A., Dimkovic, N. B., Bargman, J. M., Vas, S. I., & Oreopoulos, D. G. (2001) · Peritoneal Dialysis International · doi:10.1177/089686080102100310 · Cited by 44
Assessment of iron availability using stable54Fe
Kaltwasser, J. P., Hansen, C., OEBIKE, Y., & Werner, E. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01392.x · Cited by 18
Cited by
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
Su, Y., Zhao, B., Zhou, L., Zhang, Z., Shen, Y., Lv, H., AlQudsy, L. H. H., & Shang, P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.015 · Cited by 576
A Review of Clinical Translation of Inorganic Nanoparticles
Anselmo, A. C., & Mitragotri, S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9780-2 · Cited by 509
Locatelli, F., Bárány, P., Covic, A., De Francisco, A., Del Vecchio, L., Goldsmith, D., Hörl, W., London, G., Vanholder, R., Van Biesen, W., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft033 · Cited by 471
The Safety of Intravenous Iron Preparations
Avni, T., Bieber, A., Grossman, A., Green, H., Leibovici, L., & Gafter-Gvili, A. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.007 · Cited by 441
Metadata
- Authors
- Spinowitz, B. S., Kausz, A. T., Baptista, J., Noble, S. D., Sothinathan, R., Bernardo, M. V., Brenner, L., & Pereira, B. J. G.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2008-08
- Volume
- 19
- Issue
- 8
- Pages
- 1599-1605
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2126101850
- Cited by
- 262
- References
- 42
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.